19:55 , Nov 6, 2017 |  BC Innovations  |  Distillery Therapeutics

Cardiovascular

INDICATION: Heart failure Cell culture and mouse studies suggest GHRH receptor agonists could help treat heart failure. In a rat cardiomyoblast cell line, primary rat ventricular myocytes and human induced pluripotent stem (iPS) cell-derived cardiomyocyte...
08:00 , Nov 19, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Growth hormone-releasing hormone (GHRH) receptor

Endocrine/metabolic disease INDICATION: Diabetes In vitro and mouse studies suggest GHRH receptor agonists could improve engraftment of islet cell transplant to treat diabetes. In a rat pancreatic β cell line, the GHRH receptor agonist MR-409 increased cell...
07:00 , Sep 8, 2014 |  BioCentury  |  Emerging Company Profile

Biscayne: Antagonizing cancer

Biscayne Pharmaceuticals Inc. is developing peptide antagonists that target three different cancer growth pathways and could provide an alternative for prostate cancer patients who have become insensitive to hormone-based therapies. The company plans to enter...